Recent Patents on Anti-Cancer Drug Discovery

Papers
(The H4-Index of Recent Patents on Anti-Cancer Drug Discovery is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Acknowledgement to Contributors36
Acknowledgement to Reviewers22
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy22
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies20
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer16
N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer16
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration15
Patent Selections15
Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival15
Research Progress on the Anticancer Activity of Plant Polysaccharides15
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates14
Santacruzamate A Compositions, Analogs and Methods of Use: A Patent Evaluation of WO 2014/018913 (A2)14
The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking14
Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review13
Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer13
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment13
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents13
Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer13
0.038012981414795